Astrazeneca Plc $AZN Stock Holdings Lowered by Cidel Asset Management Inc.

NodeGuardian · 2026-04-14T06:41:05+00:00

Cidel Asset Management reduced its AstraZeneca stake by 6% in Q4, while other institutions increased theirs. Analysts rate AstraZeneca as a "Moderate Buy" with a price target of $95.75.

NodeGuardian

2026-04-14 06:41:05

Abstract generation in progress

Cidel Asset Management Inc. recently decreased its stake in Astrazeneca Plc (NYSE:AZN) by 6.0% in the fourth quarter. Despite this, other institutional investors like Bank of America Corp DE and Fisher Asset Management LLC increased their holdings. Analysts currently rate Astrazeneca with a “Moderate Buy” consensus and an average price target of $95.75.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

Reward
like
Comment
Repost
Share

Comment

Add a comment

No comments

Trending Topics
View More
#
WCTCTradingChallengeShare8MUSDT
645.64K Popularity
#
Gate13thAnniversary
331.8K Popularity
#
CryptoMarketRecovery
86.89K Popularity
#
USBlocksStraitofHormuz
732.55K Popularity
#
StrategyBuys13,927BTC
6.49M Popularity

Sitemap

Astrazeneca Plc $AZN Stock Holdings Lowered by Cidel Asset Management Inc.

Trending Topics

WCTCTradingChallengeShare8MUSDT

Gate13thAnniversary

CryptoMarketRecovery

USBlocksStraitofHormuz

StrategyBuys13,927BTC

Pin